Cargando…

Non-surgical treatment with XSHHD for ruptured lumbar disc herniation: a 3-year prospective observational study

BACKGROUND: Lumbar disc herniation (LDH) is mainly caused by annular fiber disruption with a discrete leakage of nucleus pulposus pressing on a nerve, resulting in back pain and radiating pain. Most patients with LDH can be treated conservatively, but there are many different conservative treatments...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Feng, Dai, Yu Xiang, Jiang, Hong, Yu, Peng Fei, Liu, Jin Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574183/
https://www.ncbi.nlm.nih.gov/pubmed/33076896
http://dx.doi.org/10.1186/s12891-020-03723-2
_version_ 1783597590430875648
author Dai, Feng
Dai, Yu Xiang
Jiang, Hong
Yu, Peng Fei
Liu, Jin Tao
author_facet Dai, Feng
Dai, Yu Xiang
Jiang, Hong
Yu, Peng Fei
Liu, Jin Tao
author_sort Dai, Feng
collection PubMed
description BACKGROUND: Lumbar disc herniation (LDH) is mainly caused by annular fiber disruption with a discrete leakage of nucleus pulposus pressing on a nerve, resulting in back pain and radiating pain. Most patients with LDH can be treated conservatively, but there are many different conservative treatments. Furthermore, most previous studies did not evaluate the long-term efficacy of these treatments and the prognosis. Therefore, an effective and safe therapeutic strategy is lacking for patients with LDH. In this study, we evaluated Xiao Sui Hua He decoction (XSHHD) in the treatment of LDH. METHODS: This was a rigorous prospective observational 3-year follow-up study. We recruited 69 participants with ruptured lumbar disc herniation (RLDH) between February 2014 and February 2016. Patients took XSHHD orally twice a day for 6 months. The primary outcome measurements were visual analogue scale (VAS) pain score, Oswestry disability index (ODI) and straight leg raising test (SLRT). The secondary outcome measurements was nucleus pulposus protrusion volume on magnetic resonance imaging (MRI). Clinical outcomes were measured at baseline (Visit 1), and at 3, 6, 12, and 36 months (Visit 2, 3, 4, and 5, respectively).. RESULTS: Sixty-three patients were followed-up for 3 years after treatment. SLRT and ODI after non-surgical treatment improved significantly compared with baseline (P < .001). There were no statistically significant differences at 6 months vs 36 months for SLRT and ODI. VAS scores (leg, back) after 3 years of treatment were statistically significantly different compared with baseline (P < .001; Z = − 6.93, − 6.637). The baseline protrusion volume was 2018.61 ± 601.16 mm(3), and the volume decreased significantly to 996.51 ± 387.42 mm3 at 36 months (t = 12.863; P < .001). The volume of protrusion resorption rate (VPRR) at 36 months was 47.24 ± 23.99%, with significant resorption in 23 cases, partial resorption in 23 cases, no resorption in 15 cases, and increased volume in 2 cases. CONCLUSIONS: This study showed that non-surgical treatment with XSHHD was effective, and the study clarified the natural outcomes in LDH.
format Online
Article
Text
id pubmed-7574183
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75741832020-10-20 Non-surgical treatment with XSHHD for ruptured lumbar disc herniation: a 3-year prospective observational study Dai, Feng Dai, Yu Xiang Jiang, Hong Yu, Peng Fei Liu, Jin Tao BMC Musculoskelet Disord Research Article BACKGROUND: Lumbar disc herniation (LDH) is mainly caused by annular fiber disruption with a discrete leakage of nucleus pulposus pressing on a nerve, resulting in back pain and radiating pain. Most patients with LDH can be treated conservatively, but there are many different conservative treatments. Furthermore, most previous studies did not evaluate the long-term efficacy of these treatments and the prognosis. Therefore, an effective and safe therapeutic strategy is lacking for patients with LDH. In this study, we evaluated Xiao Sui Hua He decoction (XSHHD) in the treatment of LDH. METHODS: This was a rigorous prospective observational 3-year follow-up study. We recruited 69 participants with ruptured lumbar disc herniation (RLDH) between February 2014 and February 2016. Patients took XSHHD orally twice a day for 6 months. The primary outcome measurements were visual analogue scale (VAS) pain score, Oswestry disability index (ODI) and straight leg raising test (SLRT). The secondary outcome measurements was nucleus pulposus protrusion volume on magnetic resonance imaging (MRI). Clinical outcomes were measured at baseline (Visit 1), and at 3, 6, 12, and 36 months (Visit 2, 3, 4, and 5, respectively).. RESULTS: Sixty-three patients were followed-up for 3 years after treatment. SLRT and ODI after non-surgical treatment improved significantly compared with baseline (P < .001). There were no statistically significant differences at 6 months vs 36 months for SLRT and ODI. VAS scores (leg, back) after 3 years of treatment were statistically significantly different compared with baseline (P < .001; Z = − 6.93, − 6.637). The baseline protrusion volume was 2018.61 ± 601.16 mm(3), and the volume decreased significantly to 996.51 ± 387.42 mm3 at 36 months (t = 12.863; P < .001). The volume of protrusion resorption rate (VPRR) at 36 months was 47.24 ± 23.99%, with significant resorption in 23 cases, partial resorption in 23 cases, no resorption in 15 cases, and increased volume in 2 cases. CONCLUSIONS: This study showed that non-surgical treatment with XSHHD was effective, and the study clarified the natural outcomes in LDH. BioMed Central 2020-10-19 /pmc/articles/PMC7574183/ /pubmed/33076896 http://dx.doi.org/10.1186/s12891-020-03723-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Dai, Feng
Dai, Yu Xiang
Jiang, Hong
Yu, Peng Fei
Liu, Jin Tao
Non-surgical treatment with XSHHD for ruptured lumbar disc herniation: a 3-year prospective observational study
title Non-surgical treatment with XSHHD for ruptured lumbar disc herniation: a 3-year prospective observational study
title_full Non-surgical treatment with XSHHD for ruptured lumbar disc herniation: a 3-year prospective observational study
title_fullStr Non-surgical treatment with XSHHD for ruptured lumbar disc herniation: a 3-year prospective observational study
title_full_unstemmed Non-surgical treatment with XSHHD for ruptured lumbar disc herniation: a 3-year prospective observational study
title_short Non-surgical treatment with XSHHD for ruptured lumbar disc herniation: a 3-year prospective observational study
title_sort non-surgical treatment with xshhd for ruptured lumbar disc herniation: a 3-year prospective observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574183/
https://www.ncbi.nlm.nih.gov/pubmed/33076896
http://dx.doi.org/10.1186/s12891-020-03723-2
work_keys_str_mv AT daifeng nonsurgicaltreatmentwithxshhdforrupturedlumbardischerniationa3yearprospectiveobservationalstudy
AT daiyuxiang nonsurgicaltreatmentwithxshhdforrupturedlumbardischerniationa3yearprospectiveobservationalstudy
AT jianghong nonsurgicaltreatmentwithxshhdforrupturedlumbardischerniationa3yearprospectiveobservationalstudy
AT yupengfei nonsurgicaltreatmentwithxshhdforrupturedlumbardischerniationa3yearprospectiveobservationalstudy
AT liujintao nonsurgicaltreatmentwithxshhdforrupturedlumbardischerniationa3yearprospectiveobservationalstudy